Literature DB >> 15672415

Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development.

Megan L Kerr1, David H Small.   

Abstract

The beta-amyloid protein precursor (APP) has been extensively studied for its role in amyloid production and the pathogenesis of Alzheimer's disease (AD). However, little is known about the normal function of APP and its biological interactions. In this Mini-Review, the role of the cytoplasmic domain of APP in APP trafficking and proteolysis is described. These studies suggest that proteins that bind to the cytoplasmic domain may be important targets for drug development in AD. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15672415     DOI: 10.1002/jnr.20408

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice.

Authors:  M Cachard-Chastel; F Lezoualc'h; I Dewachter; C Deloménie; S Croes; H Devijver; M Langlois; F Van Leuven; S Sicsic; A M Gardier
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

2.  Ubiquilin-1 regulates amyloid precursor protein maturation and degradation by stimulating K63-linked polyubiquitination of lysine 688.

Authors:  Amina El Ayadi; Emily S Stieren; José M Barral; Darren Boehning
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

3.  Variability in the diagnosis and management of patients with Alzheimer's disease and cerebrovascular disease: results from the GALATEA multicentre, observational study.

Authors:  Pedro Gil; José Luis Dobato Ayuso; José Manuel Marey; Manuel Antón; Carlos Guzmán Quilo
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 4.  Genetic intolerance analysis as a tool for protein science.

Authors:  Geoffrey C Li; Eliot T C Forster-Benson; Charles R Sanders
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-09-05       Impact factor: 3.747

Review 5.  Neddylation dysfunction in Alzheimer's disease.

Authors:  Yuzhi Chen; Rachael L Neve; Helena Liu
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310

6.  Dissociation of ERK signalling inhibition from the anti-amyloidogenic action of synthetic ceramide analogues.

Authors:  Hongyun Li; Genevieve Evin; Andrew F Hill; Ya Hui Hung; Ashley I Bush; Brett Garner
Journal:  Clin Sci (Lond)       Date:  2012-05       Impact factor: 6.124

Review 7.  Insights into the physiological function of the β-amyloid precursor protein: beyond Alzheimer's disease.

Authors:  Edgar Dawkins; David H Small
Journal:  J Neurochem       Date:  2014-03-07       Impact factor: 5.372

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.